1. Home
  2. INVE vs IMUX Comparison

INVE vs IMUX Comparison

Compare INVE & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • IMUX
  • Stock Information
  • Founded
  • INVE 1990
  • IMUX 2016
  • Country
  • INVE United States
  • IMUX United States
  • Employees
  • INVE N/A
  • IMUX N/A
  • Industry
  • INVE Computer peripheral equipment
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVE Technology
  • IMUX Health Care
  • Exchange
  • INVE Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • INVE 86.5M
  • IMUX 86.3M
  • IPO Year
  • INVE 1997
  • IMUX N/A
  • Fundamental
  • Price
  • INVE $3.53
  • IMUX $0.94
  • Analyst Decision
  • INVE Strong Buy
  • IMUX Strong Buy
  • Analyst Count
  • INVE 2
  • IMUX 6
  • Target Price
  • INVE $7.25
  • IMUX $12.67
  • AVG Volume (30 Days)
  • INVE 33.4K
  • IMUX 946.7K
  • Earning Date
  • INVE 03-11-2025
  • IMUX 02-20-2025
  • Dividend Yield
  • INVE N/A
  • IMUX N/A
  • EPS Growth
  • INVE N/A
  • IMUX N/A
  • EPS
  • INVE 3.10
  • IMUX N/A
  • Revenue
  • INVE $104,217,000.00
  • IMUX N/A
  • Revenue This Year
  • INVE N/A
  • IMUX N/A
  • Revenue Next Year
  • INVE N/A
  • IMUX N/A
  • P/E Ratio
  • INVE $1.15
  • IMUX N/A
  • Revenue Growth
  • INVE 70.57
  • IMUX N/A
  • 52 Week Low
  • INVE $2.95
  • IMUX $0.92
  • 52 Week High
  • INVE $9.24
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • INVE 45.23
  • IMUX 38.85
  • Support Level
  • INVE $3.50
  • IMUX $0.94
  • Resistance Level
  • INVE $3.80
  • IMUX $1.02
  • Average True Range (ATR)
  • INVE 0.19
  • IMUX 0.06
  • MACD
  • INVE 0.00
  • IMUX 0.00
  • Stochastic Oscillator
  • INVE 29.79
  • IMUX 13.58

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: